Japan Lifeline Co., Ltd. (FRA:L8B)

Market Cap	518.57M -21.6%
Revenue (ttm)	316.17M +4.1%
Net Income	49.25M +7.8%
EPS	0.70 +10.8%
Shares Out	n/a
PE Ratio	10.53
Forward PE	n/a
Dividend	0.29 (3.90%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Average Volume	n/a
Open	7.25
Previous Close	7.25
Day's Range	7.25 - 7.25
52-Week Range	7.22 - 9.49
Beta	n/a
RSI	39.02
Earnings Date	May 7, 2026

About Japan Lifeline

Japan Lifeline Co., Ltd., a medical device company, engages in manufacturing and sale of medical device in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablat...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1981
• Employees: 1,250
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: L8B

Financial Performance

In fiscal year 2025, Japan Lifeline's revenue was 56.61 billion, an increase of 10.17% compared to the previous year's 51.38 billion. Earnings were 9.32 billion, an increase of 23.98%.

Financial numbers in JPY